An Institute of Medicine report on the issues underlying the Duke University/Anil Potti research scandal has found that there are problems with the use of genetic signatures to treat or diagnose disease, reports ScienceInsider's Jocelyn Kaiser.
Registering provides access to this and other free content.
Already have an account?Login Now.
CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.
Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.
Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.
In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.